Two Sigma Advisers
IART icon

Two Sigma Advisers’s Integra LifeSciences IART Stock Holding History

Two Sigma Advisers’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-194,300
Closed -$2.41M – 1008
2025
Q4 		$2.41M Sell
194,300
-176,700
-48% -$2.35M ﹤0.01% 1107
2025
Q3 		$5.32M Sell
371,000
-37,400
-9% -$512K 0.01% 725
2025
Q2 		$5.01M Sell
408,400
-24,300
-6% -$353K 0.01% 741
2025
Q1 		$9.52M Sell
432,700
-103,300
-19% -$2.43M 0.02% 548
2024
Q4 		$12.2M Buy
536,000
+23,300
+5% +$509K 0.03% 431
2024
Q3 		$9.32M Sell
512,700
-17,800
-3% -$413K 0.02% 507
2024
Q2 		$15.5M Sell
530,500
-35,800
-6% -$1.06M 0.03% 405
2024
Q1 		$20.1M Buy
566,300
+8,900
+2% +$356K 0.05% 342
2023
Q4 		$24.3M Sell
557,400
-41,100
-7% -$1.62M 0.06% 291
2023
Q3 		$22.9M Buy
598,500
+197,100
+49% +$8.29M 0.06% 280
2023
Q2 		$16.5M Buy
401,400
+33,400
+9% +$1.61M 0.04% 350
2023
Q1 		$21.1M Sell
368,000
-44,000
-11% -$2.48M 0.05% 318
2022
Q4 		$23.1M Sell
412,000
-106,000
-20% -$5.4M 0.06% 300
2022
Q3 		$21.9M Buy
518,000
+28,200
+6% +$1.44M 0.06% 300
2022
Q2 		$26.5M Buy
489,800
+352,200
+256% +$21.2M 0.08% 270
2022
Q1 		$8.84M Buy
137,600
+131,200
+2,050% +$8.64M 0.02% 562
2021
Q4 		$429K Buy
+6,400
New +$433K ﹤0.01% 1988
2020
Q3 		– Sell
-20,126
Closed -$946K – 2505
2020
Q2 		$946K Buy
20,126
+8,700
+76% +$428K ﹤0.01% 1597
2020
Q1 		$510K Sell
11,426
-61,500
-84% -$3.23M ﹤0.01% 1801
2019
Q4 		$4.25M Sell
72,926
-52,400
-42% -$3.12M 0.01% 908
2019
Q3 		$7.53M Buy
125,326
+7,300
+6% +$435K 0.02% 630
2019
Q2 		$6.59M Buy
118,026
+65,600
+125% +$3.38M 0.02% 722
2019
Q1 		$2.92M Buy
+52,426
New +$2.67M 0.01% 1061
2018
Q4 		– Sell
-9,046
Closed -$596K – 2401
2018
Q3 		$596K Sell
9,046
-6,500
-42% -$404K ﹤0.01% 1725
2018
Q2 		$1M Buy
+15,546
New +$963K ﹤0.01% 1607
2017
Q3 		– Sell
-288,028
Closed -$15.7M – 2268
2017
Q2 		$15.7M Sell
288,028
-66,800
-19% -$3.19M 0.05% 393
2017
Q1 		$14.9M Buy
354,828
+156,902
+79% +$6.7M 0.05% 443
2016
Q4 		$8.49M Buy
197,926
+192,000
+3,240% +$7.8M 0.03% 518
2016
Q3 		$245K Sell
5,926
-6,600
-53% -$277K ﹤0.01% 1962
2016
Q2 		$500K Sell
12,526
-115,400
-90% -$4.15M ﹤0.01% 1520
2016
Q1 		$4.31M Sell
127,926
-1,200
-0.9% -$37.4K 0.02% 552
2015
Q4 		$4.38M Sell
129,126
-128,800
-50% -$4.03M 0.03% 483
2015
Q3 		$7.68M Buy
257,926
+151,595
+143% +$4.74M 0.05% 378
2015
Q2 		$2.93M Buy
106,331
+72,660
+216% +$1.94M 0.02% 656
2015
Q1 		$848K Buy
33,671
+1,223
+4% +$28.9K 0.01% 1143
2014
Q4 		$719K Sell
32,448
-244
-0.7% -$4.95K 0.01% 1371
2014
Q3 		$663K Sell
32,692
-29,358
-47% -$584K 0.01% 1373
2014
Q2 		$1.19M Sell
62,050
-5,871
-9% -$109K 0.01% 1072
2014
Q1 		$1.28M Buy
67,921
+57,247
+536% +$1.1M 0.01% 1003
2013
Q4 		$208K Buy
+10,674
New +$196K ﹤0.01% 2117

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers's IART Position: Q1 2026 in Review

Two Sigma Advisers sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 194,300 shares — an estimated $2.41M sold.

Two Sigma Advisers first reported a position in IART in Q4 2013 and held it in 40 quarters. The position peaked at $26.5M in Q2 2022. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Two Sigma Advisers reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 194,300 Integra LifeSciences shares in Q1 2026, an estimated $2.41M.
  • Two Sigma Advisers first reported a position in Integra LifeSciences in Q4 2013 and held it in 40 quarters.
  • Two Sigma Advisers's Integra LifeSciences position peaked at $26.5M in Q2 2022.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.